DrugDashboards

Market view

lisinopril/hctz

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for lisinopril/hctz, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Lisinopril/HCTZSep 2, 2026
    Mfr exited
    Direct_Rx · lisinopril/hctz
  • Lisinopril/HCTZAug 26, 2026
    Mfr entered
    Direct_Rx · lisinopril/hctz
  • Lisinopril/HCTZJul 29, 2026
    Mfr exited
    Direct_Rx · lisinopril/hctz
  • Lisinopril/HCTZJul 22, 2026
    Mfr entered
    Direct_Rx · lisinopril/hctz

Same drug class

Other molecules FDA puts in Angiotensin Converting Enzyme Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Lisinopril/hctz in shortage right now?
No. FDA does not currently list Lisinopril/hctz in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Lisinopril/hctz?
1 company has marketed Lisinopril/hctz in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.